Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Venture Investments Ltd Morningside currently holds 4,997,302 shares of Apellis Pharmaceuticals, Inc. (APLS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Venture Investments Ltd Morningside has been a net buyer of APLS stock. They have purchased $80.3M and sold $26.4M worth of shares.
Venture Investments Ltd Morningside's most recent insider trade was on Aug 15, 2023, when they sold 2,000,000 shares at $0.00 per share.
Venture Investments Ltd Morningside serves as Executive at Apellis Pharmaceuticals, Inc. (APLS). They have executed 67 insider transactions totaling $106.7M over their tenure at the company.
Venture Investments Ltd Morningside holds the position of Executive at Apellis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Venture Investments Ltd Morningside has shown a buying trading pattern, with $80.3M in total purchases and $26.4M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Venture Investments Ltd Morningside was on Aug 11, 2022, when they purchased $12.0M worth of GRNA shares. This transaction involved 3,061,224 shares at $3.92 per share.
Venture Investments Ltd Morningside currently owns 4,997,302 shares of Apellis Pharmaceuticals, Inc. (APLS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Venture Investments Ltd Morningside's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Venture Investments Ltd Morningside has 67 Form 4 filings on record as an insider at Apellis Pharmaceuticals, Inc..
Set alerts for Venture Investments Ltd Morningside and 40,000+ other insiders.